Written Question·Department of Health and Social Care·UIN 32712
Trastuzumab Deruxtecan: Scotland
Tabled: 21 February 2025
Answered: 26 February 2025
Question
James MacCleary
Liberal Democrat — Lewes
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of the availability of Enhertu in (a) Scotland and (b) Europe compared to (c) England and (d) Wales.
Answer
Karin SmythHealth is a devolved matter and decisions on the availability of medicines in Scotland and Wales are a matter for their own administrations. Other European countries operate very different health systems and direct comparisons of medicine availability are...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 32712) →
Partner sites